根据名称进行药物检索

Ketoprofen Capsules与贫血

Ketoprofen Capsules与贫血安全配伍检测的结果。

检测结果:

Ketoprofen Capsules <> 贫血

现实性: 23.07.2019 评论家: 医学副博士Shkutko P.M., in

通过权威的信息来源 Drugs.com、Rxlist.com、Webmd.com、Medscape.com，在进行所选药物与这种伴发疾病互相作用检测时，发现一些会产生负面影响或对身体危害的禁忌症及副作用。

用户:

剂量依赖性下降的血红蛋白和红细胞已经观察到治疗的患者非甾体抗炎药(非甾体抗炎药). 贫血已经报道的偶尔。该机制可能涉及非甾体诱导的液体潴留或肠胃失血，或不完全的描述的影响红细胞生成。减少的血红蛋白的浓度往往是轻微的平均剂量但可能超过1g/dL当大剂量给予，如用于治疗关节炎或类风湿性关节炎。虽然这些影响是一般临床不重要的其他健康个人，他们可能是相关的，在患有先前存在的贫血症或大量失血。治疗与药物，应给予谨慎的患者或易患贫血症。临床监测的造血功能可能是合适的，特别是在慢性治疗。

来源

"Product Information. Relafen (nabumetone)." SmithKline Beecham, Philadelphia, PA.
Salom IL, Jacob G, Jallad N, Perdomo CA, Mullane JF, Weidler D "Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males." J Clin Pharmacol 24 (1984): 240-6
"Product Information. Celebrex (celecoxib)." Searle, Chicago, IL.
Johnson FP Jr, Hamilton HE, Liesch MR "Immune hemolytic anemia associated with sulindac." Arch Intern Med 145 (1985): 1515-6
"Product Information. Indocin (indomethacin)." Merck & Co, Inc, West Point, PA.
Squires JE, Mintz PD, Clark S "Tolmetin-induced hemolysis." Transfusion 25 (1985): 410-3
Kornberg A, Rachmilewitz EA "Aplastic anemia after prolonged ingestion of indomethacin." Acta Haematol 67 (1982): 136-8
Eustace S, O'Neill T, McHale S, Molony J "Fatal aplastic anaemia following prolonged diclofenac use in an elderly patient." Ir J Med Sci 158 (1989): 217
Catalano MA "Worldwide safety experience with diclofenac." Am J Med 80 (1986): 81-7
"Product Information. Lodine (etodolac)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Ansaid (flurbiprofen)." Pharmacia and Upjohn, Kalamazoo, MI.
"Product Information. Clinoril (sulindac)." Merck & Co, Inc, West Point, PA.
Randi ML, Tison T, Luzzatto G "Haemolytic uraemic syndrome during treatment with ketorolac trometamol." BMJ 306 (1993): 186
Sanz MA, Martinez JA, Gomis F, Garcia-Borras JJ "Sulindac-induced bone marrow toxicity." Lancet 2 (1980): 802-3
Bernhard GC "Worldwide safety experience with nabumetone." J Rheumatol 19 (1992): 48-57
"Product Information. Tolectin (tolmetin)." McNeil Pharmaceutical, Raritan, NJ.
"Product Information. Dolobid (diflunisal)." Merck & Co, Inc, West Point, PA.
Ashraf M, Pearson RM, Winfield DA "Aplastic anaemia associated with fenoprofen." Br Med J 284 (1982): 1301-2
Andrews R, Russell N "Aplastic anaemia associated with a non-steroidal anti-inflammatory drug: relapse after exposure to another such drug." Br Med J 301 (1990): 38
Lee SH, Fawcett V, Preece JM "Aplastic anaemia associated with piroxicam." Lancet 1 (1982): 1186
Reitz CL, Bottomley SS "Pure red cell aplasia associated with fenoprofen." Am J Med Sci 287 (1984): 62-3
Sanada M, Takai K "Aplastic anaemia associated with piroxicam." Br J Haematol 77 (1991): 256-7
Miller JL "Marrow aplasia and sulindac." Ann Intern Med 92 (1980): 129
"Product Information. Naprosyn (naproxen)." Syntex Laboratories Inc, Palo Alto, CA.
Brooks CD, Linet OI, Schellenberg D, Turner LF, Defesche CL, Teoh KW, Johnson JH, Assenzo JR "Clinical safety of flurbiprofen." J Clin Pharmacol 30 (1990): 342-51
Schattenkirchner M "An updated safety profile of etodolac in several thousand patients." Eur J Rheumatol Inflamm 10 (1990): 56-65
Hughes JA, Sudell W "Hemolytic anemia associated with naproxen." Arthritis Rheum 26 (1983): 1054
Kramer MR, Levene C, Hershko C "Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy." Scand J Haematol 36 (1986): 118-20
Lopez A, Linares M, Sanchez H, Blanquer A "Autoimmune hemolytic anemia induced by diclofenac." Ann Pharmacother 29 (1995): 787
"Product Information. Toradol (ketorolac)." Roche Laboratories, Nutley, NJ.
McNeil P, MacKenzie I, Manoharan A "Naproxen-associated aplastic anaemia." Med J Aust 145 (1986): 53-5
Lussier A, LeBel E "Radiochromium (chromium-51) evaluation of gastrointestinal blood loss associated with placebo, aspirin, and nabumetone." Am J Med 83 (1987): 15-8
"Product Information. Vioxx (rofecoxib)." Merck & Co, Inc, West Point, PA.
"Product Information. Motrin (ibuprofen)." Pharmacia and Upjohn, Kalamazoo, MI.
van Dijk BA, Rico PB, Hoitsma A, Kunst VA "Immune hemolytic anemia associated with tolmetin and suprofen." Transfusion 29 (1989): 638-41
Schattner A, Shtalrid M, Levy R, Berrebi A "Fatal aplastic anemia due to indomethacin: lymphocyte transformation tests in vitro." Isr J Med Sci 17 (1981): 433-6
Green D, Davies RO, Holmes GI et al "Effects of diflunisal on platelet function and fecal blood loss." Pharmacotherapy 3 (1983): s65-9
"Product Information. Nalfon (fenoprofen)." Xspire Pharma, Ridgeland, MS.
"Product Information. Orudis (ketoprofen)." Wyeth-Ayerst Laboratories, Philadelphia, PA.
"Product Information. Bextra (valdecoxib)." Pharmacia Corporation, Peapack, NJ.
Bennett L, Schlossman R, Rosenthal J, et al "Aplastic anemia and sulindac." Ann Intern Med 92 (1980): 874
Arnold R, Heimpel H "Aplastic anaemia after naproxen?" Lancet 02/09/80 (1980): 321
Angeles ML, Reid ME, Yacob UA, Cash KL, Fetten JV "Sulindac-induced immune hemolytic anemia." Transfusion 34 (1994): 255-8
Gerber D "Adverse reactions of piroxicam." Drug Intell Clin Pharm 21 (1987): 707-10
"Product Information. Voltaren (diclofenac)." Novartis Pharmaceuticals, East Hanover, NJ.
"Product Information. Feldene (piroxicam)." Pfizer US Pharmaceuticals, New York, NY.
"Product Information. Daypro (oxaprozin)." Searle, Skokie, IL.
Salama A, Gottsche B, Mueller-Eckhardt C "Autoantibodies and drug- or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis." Br J Haematol 77 (1991): 546-9
"Product Information. Mobic (meloxicam)" Boehringer-Ingelheim, Ridgefield, CT.